Business Description
Solasia Pharma KK
ISIN : JP3436500007
Compare
Compare
Traded in other countries / regions
4597.Japan9SO.Germany IPO Date
2017-04-06Description
Solasia Pharma KK develops and distributes pharmaceuticals and medical devices relating to malignant tumors.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 21.41 | |||||
| Equity-to-Asset | 0.86 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.05 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 13.9 | |||||
| Beneish M-Score | -5.11 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -1.7 | |||||
| 3-Year EBITDA Growth Rate | 50.3 | |||||
| 3-Year EPS without NRI Growth Rate | 42.7 | |||||
| 3-Year FCF Growth Rate | 56.1 | |||||
| 3-Year Book Growth Rate | -28.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 44.1 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 61.79 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.91 | |||||
| 9-Day RSI | 38.8 | |||||
| 14-Day RSI | 42 | |||||
| 6-1 Month Momentum % | 120 | |||||
| 12-1 Month Momentum % | 26.55 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.87 | |||||
| Quick Ratio | 3.42 | |||||
| Cash Ratio | 3.11 | |||||
| Days Inventory | 424.73 | |||||
| Days Sales Outstanding | 415.5 | |||||
| Days Payable | 785.08 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -12.4 | |||||
| Shareholder Yield % | -12.33 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 30.82 | |||||
| Operating Margin % | -810.06 | |||||
| Net Margin % | -808.18 | |||||
| FCF Margin % | -307.96 | |||||
| ROE % | -65.51 | |||||
| ROA % | -52.7 | |||||
| ROIC % | -81.27 | |||||
| 3-Year ROIIC % | -131.01 | |||||
| ROC (Joel Greenblatt) % | -688.17 | |||||
| ROCE % | -63.78 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 46.67 | |||||
| PB Ratio | 4.26 | |||||
| Price-to-Tangible-Book | 7.47 | |||||
| EV-to-EBIT | -6.15 | |||||
| EV-to-EBITDA | -8.68 | |||||
| EV-to-Revenue | 49.94 | |||||
| EV-to-FCF | -16.39 | |||||
| Price-to-Net-Current-Asset-Value | 11.2 | |||||
| Price-to-Net-Cash | 11.2 | |||||
| Earnings Yield (Greenblatt) % | -16.26 | |||||
| FCF Yield % | -5.68 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Solasia Pharma KK Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.98 | ||
| EPS (TTM) (€) | -0.045 | ||
| Beta | 2.38 | ||
| Volatility % | 160.27 | ||
| 14-Day RSI | 42 | ||
| 14-Day ATR (€) | 0.00877 | ||
| 20-Day SMA (€) | 0.238 | ||
| 12-1 Month Momentum % | 26.55 | ||
| 52-Week Range (€) | 0.13 - 0.418 | ||
| Shares Outstanding (Mil) | 217.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Solasia Pharma KK Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Solasia Pharma KK Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Solasia Pharma KK Frequently Asked Questions
What is Solasia Pharma KK(FRA:9SO)'s stock price today?
The current price of FRA:9SO is €0.22. The 52 week high of FRA:9SO is €0.42 and 52 week low is €0.13.
When is next earnings date of Solasia Pharma KK(FRA:9SO)?
The next earnings date of Solasia Pharma KK(FRA:9SO) is .
Does Solasia Pharma KK(FRA:9SO) pay dividends? If so, how much?
Solasia Pharma KK(FRA:9SO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers